Menu
GeneBe

rs534112936

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 4P and 5B. PM5PP3_ModerateBP6BS2

The NM_001009944.3(PKD1):c.8405C>T(p.Pro2802Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000633 in 1,610,336 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P2802S) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000064 ( 1 hom. )

Consequence

PKD1
NM_001009944.3 missense

Scores

2
10
7

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: 7.33
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-2103653-G-A is described in Lovd as [Likely_pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.853
BP6
Variant 16-2103652-G-A is Benign according to our data. Variant chr16-2103652-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 433990.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PKD1NM_001009944.3 linkuse as main transcriptc.8405C>T p.Pro2802Leu missense_variant 23/46 ENST00000262304.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PKD1ENST00000262304.9 linkuse as main transcriptc.8405C>T p.Pro2802Leu missense_variant 23/461 NM_001009944.3 P5P98161-1

Frequencies

GnomAD3 genomes
AF:
0.0000591
AC:
9
AN:
152194
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000653
AC:
16
AN:
244982
Hom.:
0
AF XY:
0.0000895
AC XY:
12
AN XY:
134088
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000458
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000182
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000638
AC:
93
AN:
1458024
Hom.:
1
Cov.:
34
AF XY:
0.0000896
AC XY:
65
AN XY:
725314
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000824
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000135
Gnomad4 OTH exome
AF:
0.0000997
GnomAD4 genome
AF:
0.0000591
AC:
9
AN:
152312
Hom.:
0
Cov.:
31
AF XY:
0.0000806
AC XY:
6
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00186
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000496
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000502
AC:
6

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Polycystic kidney disease Benign:1
Likely benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The PKD1 p.Pro2802Leu variant was identified in 1 of 116 proband chromosomes (frequency: 0.009) from individuals or families with Autosomal Dominant Polycystic Kidney Disease (Rossetti 2003). The variant was also identified in dbSNP (ID: rs534112936) as “NA”. The variant was not found in the Clinvitae, ClinVar, GeneInsight COGR, MutDB, ADPKD Mutation Database, PKD1-LOVD, and PKD1-LOVD 3.0 databases. This variant was identified in the 1000 Genomes Project in 6 of 120,000 chromosomes (frequency: 0.00005) the Exome Aggregation Consortium (ExAC) database (released Jan 13, 2015) in 6 of 115124 chromosomes (frequency: 0.00005) of those 5 (0.0003) were South Asian and 1 (0.00001) were European (Non-Finnish), although this low number of observations and low frequency is not substantive enough to determine the prevalence of the variant in the general population and its relationship to disease. The p.Pro2802 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. The identification of this variant with a co-occurring pathogenic variant increases the likelihood this variant does not have clinical significance. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.11
Cadd
Benign
21
Dann
Uncertain
0.99
DEOGEN2
Uncertain
0.46
T;.
Eigen
Uncertain
0.46
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.84
T;T
M_CAP
Uncertain
0.19
D
MetaRNN
Pathogenic
0.85
D;D
MetaSVM
Benign
-0.57
T
MutationAssessor
Uncertain
2.6
M;M
MutationTaster
Benign
0.80
D;D
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-3.9
D;D
REVEL
Uncertain
0.34
Sift
Uncertain
0.0050
D;D
Sift4G
Uncertain
0.0050
D;D
Polyphen
1.0
D;D
Vest4
0.80
MutPred
0.78
Gain of catalytic residue at P2802 (P = 0.0062);Gain of catalytic residue at P2802 (P = 0.0062);
MVP
0.79
ClinPred
0.48
T
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.19
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs534112936; hg19: chr16-2153653; API